Multiple Sclerosis Is Increasingly Becoming A Woman's Disease
Over time, more women are developing multiple sclerosis (MS) than men, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting. In 1940, the ratio of women to men with MS in the United States was approximately two to one. By 2000, that ratio had grown to approximately four to one.
"That's an increase in the ratio of women to men of nearly 50 percent per decade," said study author Gary Cutter, PhD, of the University of Alabama at Birmingham School of Public Health. "We don't yet know why more women are developing MS than men, and more research is needed."
Factors Causing Cartilage, Bone Destruction In Arthritis Suppressed By Green Tea Compound
In rheumatoid arthritis, a person's own immune system attacks the joints by activating the synovial tissue that lines the body's movable joints, causing inflammation, swelling, pain and eventually erosion of the bone and cartilage and deformation of the joint. It is among the most debilitating forms of arthritis, often making difficult even the simplest of daily activities.
In a study presented at Experimental Biology 2007, University of Michigan Medical School scientist Dr. Salah-uddin Ahmed reported that a compound derived from green tea was able to inhibit production of several immune system molecules involved in inflammation and joint damage. The compound, named epigallocatechin-3-gallate (EGCG), an active principal of green tea extract, is a potent anti-inflammatory molecule, and also was able to inhibit production of interleukin-6 (IL-6) and prostaglandin E2, the inflammatory products found in the connective tissue of people with rheumatoid arthritis.
Green Tea Compound May Be A Therapy For Rheumatoid Arthritis
A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.
The study looks at a potent anti-inflammatory compound derived from green tea. Researchers found that the compound called epigallocatechin-3-gallate (EGCG) inhibited the production of several molecules in the immune system that contribute to inflammation and joint damage in people with rheumatoid arthritis.
Hat Tip: Custom Medical Stock Photo
Hat Tip: Medical News Today
Hat Tip: Science News Daily